MedPath

HERALD TR study

Not Applicable
Completed
Conditions
solid malignancies
Registration Number
JPRN-jRCT1080224684
Lead Sponsor
ational Cancer Center Hospital East
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
65
Inclusion Criteria

1.Enrolled in HERALD trial.
2.Informed consent for participation in the HERALD TR study is obtained at the discretion of the patient.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
exploratory<br>Analysis of cancer-related genetic abnormalities<br>Analysis of Protein expression<br>Analysis of mRNA and cfRNA expression<br>Analysis of circulating tumor cells
Secondary Outcome Measures
NameTimeMethod
other<br>-
© Copyright 2025. All Rights Reserved by MedPath